What does Jiangsu Bioperfectus Technologies Co., Ltd. do?

Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688399.SS's market cap?

Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) has a market capitalization of approximately $3.52 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 688399.SS pay a dividend?

Yes — Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) pays a dividend irregular, with a trailing-twelve-month yield of 11.99%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

688399.SS

Jiangsu Bioperfectus Technologies Co., Ltd.

SHH·Biotechnology · Healthcare

¥28.36¥0.06−0.21%

Market cap¥3.52B·Aug 26 7:00 AM UTC

Price Chart

¥28.36−¥0.06 (−0.21%)today

−54.62%CAGR −14.62%

Select date range

FromTo

Dec 5, 2019Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)11.99%

Annual Dividend (FWD)¥3.40

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio43.0%

FCF Payout Ratio—

Most Recent Dividend¥3.40

Ex-Dividend DateSep 11

Payment DateSep 11

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 23

Last Report DateApr 29

Reported vs Estimate¥0.25

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥326.02M

Net Income−¥32.78M

Net Margin−10.1%

Operating Cash Flow¥23.42M

Capital Expenditures¥93.61M

Free Cash Flow−¥70.19M

Return on Equity−1.1%

Return on Invested Capital0.6%

Net Cash¥1.17B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688399.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688399.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688399.SS and 80,000+ other tickers.

About Jiangsu Bioperfectus Technologies Co., Ltd.

Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.

CEO: Guoqiang Wang
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 581
Website: www.s-sbio.com

Peers

Peers Tab

688488.SS

Jiangsu Aidea Pharmaceutical Co., Ltd.

Cap

¥6.9B

688767.SS

Hangzhou Biotest Biotech Co.,Ltd.

Cap

¥5.3B

300147.SZ

Xiangxue Pharmaceutical Co.,Ltd.

Cap

¥4.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688399.SS

What does Jiangsu Bioperfectus Technologies Co., Ltd. do?: Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688399.SS's market cap?: Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) has a market capitalization of approximately $3.52 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 688399.SS pay a dividend?: Yes — Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) pays a dividend irregular, with a trailing-twelve-month yield of 11.99%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.